Hitachi Secures Contract for Mexican Railway Signaling System Fed Chair Kevin Warsh Signals Potential GreenspanInspired Monetary Policy Approach Retail Shareholding Declines in Major Indian Stocks During Q4 ATT CEO Highlights BlueCollar Worker Shortage as AI Reshapes Job Market College Graduates Face New Challenges SP 500 Edges Higher as Consumer Stocks Offset Energy and Tech Weakness Deleted Disclosure in SpaceXs S1 May Shed Light on AI Infrastructure Economics HE Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Enova International ENVA Q1 2026 Earnings EPS Beats Estimates by 335 Stock Rises HHH Q1 2026 Earnings Earnings Per Share Beat Estimates by 73 Stock Declines Slightly Motorsport Games Q1 2026 Earnings Unexpected Profitability Achieved Amidst Disclosed Challenges TATT Q1 2026 Earnings Strong EPS Beat Signals Momentum in Aerospace Defense Blue Foundry Bancorp BLFY Holds Steady at 1324 as Trading Range Tightens Fusemachines FUSE Holds Steady Near 142 as Key Levels Come into Focus AFLAC Holds Steady Near 118 as Support and Resistance Levels Come into Focus Aon Holds Steady Near Support as AON Stock Consolidates in Tight Range SFL Corporation SFL Faces Pressure Stock Declines 285 Amid Broader Shipping Sector Headwinds Micron Surges to 10th Largest US Company Wall Street Eyes Potential to Overtake Tesla and Meta Voyager Therapeutics Q1 2026 Earnings EPS Beats Estimates as Stock Rises Amid Pipeline Progress Pantages Capital Acquisition Right PGACR Holds at 021 Low Volatility Persists for SPAC Right TTWO Q1 2026 Earnings Strong EPS Beat Fails to Lift Shares Virtu Financial Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher REGCO Q1 2026 Earnings Preferred Stock EPS Beats Estimates Stock Edges Lower Medtronic MDT Q1 2026 Earnings Slight EPS Beat on Solid Operational Execution ES Q1 2026 Earnings EPS Falls Short of Consensus CVSA Q1 2026 Earnings Strong EPS Surprise Drives Optimistic Start to Fiscal Year ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds